IP Library Granted Patent US 9,562,011
Granted Patent B2
US 9,562,011 · App. 14/608,262 · Granted Feb 7, 2017

Methods of producing molindone and its salts

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,562,011
App. No.
14/608,262
Granted
Feb 7, 2017
Kind
B2
Abstract

The present invention is directed towards novel methods of synthesis of molindone, synthesis of the intermediates of molindone, and high-purity compositions of molindone. In particular, the invention relates to the methods of synthesis of molindone through the Mannich reaction.

Claims (20)

1. A process for preparing 2-methyl-3-ethyl-4-oxo-4,5,6,7-tetrahydroindole (SUMO-2), comprising reacting 2,3-pentanedione-2-oxime (SUMO-1) with 1,3-cyclohexanedione

2. A process for preparing 2-methyl-3-ethyl-4-oxo-4,5,6,7-tetrahydroindole (SUMO-2), comprising reacting 2-amino-pentan-3-one with 1,3-cyclohexanedione

3. The process according to claim 1 further comprising:

(a) forming formyl SUMO-2 by reacting SUMO-2 with ethyl formate;

(b) reacting formyl SUMO-2 with morpholine to form an enamine of formyl SUMO-2; and

(c) reducing the enamine to form molindone

4. The process according to claim 1 , carried out under hydrogenating conditions and in the presence of a catalyst.

5. The process according to claim 1 , carried out as a single stage reaction.

6. The process according to claim 5 , carried out in the presence of an organic or inorganic acid selected from the group consisting of hydrochloric acid, sulfuric acid, nitric acid, formic acid, acetic acid, trifluoroacetic acid, and combinations thereof.

7. The process according to claim 1 , carried out as a two-stage reaction, wherein the first stage of the reaction is a hydrogenation stage and the second stage is a cyclization stage.

8. The process according to claim 7 , wherein the hydrogenation stage is carried out at a temperature of from 15° C. to 40° C. and the cyclization stage is carried out at a temperature from 70° C. to 110° C.

9. The process according to claim 8 , wherein the 1,3-cyclohexanedione is added at the cyclization stage.

10. The process according to claim 8 , wherein the hydrogenation stage is carried out in the presence of a catalyst selected from the group consisting of Raney nickel catalyst, PtO 2 , and Pd catalyst.

11. The process according to claim 2 , carried out under hydrogenating conditions and in the presence of a catalyst.

12. The process according to claim 2 , carried out as a single stage reaction.

13. The process according to claim 12 , carried out in the presence of an organic or inorganic acid selected from the group consisting of hydrochloric acid, sulfuric acid, nitric acid, formic acid, acetic acid, trifluoroacetic acid, and combinations thereof.

14. The process according to claim 2 , carried out as a two-stage reaction, wherein the first stage of the reaction is a hydrogenation stage and the second stage is a cyclization stage.

15. The process according to claim 14 , wherein the hydrogenation stage is carried out at a temperature of from 15° C. to 40° C. and the cyclization stage is carried out at a temperature from 70° C. to 110° C.

16. The process according to claim 15 , wherein the 1,3-cyclohexanedione is added at the cyclization stage.

17. The process according to claim 15 , wherein the hydrogenation stage is carried out in the presence of a catalyst selected from the group consisting of Raney nickel catalyst, PtO 2 , and Pd catalyst.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Nov 30, 2017
From: U.S. BANK NATIONAL ASSOCIATION
To: SUPERNUS PHARMACEUTICALS, INC.
Reel/Frame 044552/0694 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2015
From: FUMAGALLI, TIZIANO
To: SUPERNUS PHARMACEUTICALS, INC.
Reel/Frame 035659/0351 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 14, 2015
From: HANBAUER, MARTIN; NAZIR, ZARGHUN; HILDEBRAND, PETER; FIGINI, ATTILIA; LIANG, LIKAN
To: SUPERNUS PHARMACEUTICALS, INC.
Reel/Frame 035402/0960 →